Skip to main content
. 2017 Oct 1;10(10):10515–10521.

Table 2.

Clinical characteristics and fasting serum adiponectin levels of 150 diabetic patients

Characteristic Number (%) Adiponectin (ng/ml) P value
Gender Male 89 (55.7) 29.43 ± 10.10 0.695
Female 61 (44.3) 30.16 ± 12.29
Hypertension No 72 (47.9) 29.15 ± 10.47 0.542
Yes 78 (52.1) 30.26 ± 11.53
Statin No 79 (50.9) 30.32 ± 10.49 0.492
Yes 71 (49.1) 29.07 ± 11.60
Fibrate No 141 (94.5) 29.93 ± 11.24 0.371
Yes 9 (5.5) 26.53 ± 5.87
Metformin No 67 (44.8) 29.63 ± 11.42 0.921
Yes 83 (55.2) 29.81 ± 10.74
Sulfonylureas No 69 (46.7) 30.27 ± 10.60 0.583
Yes 81 (53.3) 29.27 ± 11.40
DDP-4 inhibitor No 60 (39.4) 29.92 ± 10.36 0.860
Yes 90 (60.6) 29.60 ± 11.48
Thiazolidinediones No 148 (97.0) 29.55 ± 10.95 0.083
Yes 2 (3.0) 43.13 ± 9.26
Insulin No 109 (73.9) 30.14 ± 11.75 0.451
Yes 41 (26.1) 28.62 ± 8.77

Data are expressed as means ± standard deviations. *P < 0.05 was considered statistically significant after Student’s t-test. DDP-4, dipeptidyl peptidase 4.